Eyebright Medical Technology Beijing Co Ltd (688050) — Cash Flow Reinvestment Rate
Eyebright Medical Technology Beijing Co Ltd (688050) has a Cash Flow Reinvestment Rate of 0.28x as of September 2025, reinvesting CN¥21.37 Million (capex CN¥21.37 Million ) from operating cash flow of CN¥76.92 Million. Explore capital reinvestment ratio of Eyebright Medical Technology Beijing Co to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Eyebright Medical Technology Beijing Co Ltd Cash Flow Reinvestment Rate (2017–2025)
Historical reinvestment intensity for Eyebright Medical Technology Beijing Co Ltd across 9 annual periods. Also explore Eyebright Medical Technology Beijing Co total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Eyebright Medical Technology Beijing Co Ltd (2017–2025)
Year-by-year capital reinvestment analysis for Eyebright Medical Technology Beijing Co Ltd. For live market cap and broader valuation context, see Eyebright Medical Technology Beijing Co market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.35x | CN¥130.32 Million | CN¥369.15 Million | CN¥123.14 Million | ▼ -77.3% |
| 2024 | 1.56x | CN¥541.48 Million | CN¥347.75 Million | CN¥329.48 Million | ▼ -12.6% |
| 2023 | 1.78x | CN¥403.01 Million | CN¥226.27 Million | CN¥370.34 Million | ▼ -23.0% |
| 2022 | 2.31x | CN¥578.87 Million | CN¥250.13 Million | CN¥271.03 Million | ▼ -30.6% |
| 2021 | 3.34x | CN¥731.58 Million | CN¥219.30 Million | CN¥311.22 Million | ▼ -41.7% |
| 2020 | 5.73x | CN¥706.44 Million | CN¥123.35 Million | CN¥118.73 Million | ▲ +40.7% |
| 2019 | 4.07x | CN¥205.59 Million | CN¥50.49 Million | CN¥141.61 Million | ▲ +80.4% |
| 2018 | 2.26x | CN¥71.81 Million | CN¥31.82 Million | CN¥71.81 Million | ▼ -70.3% |
| 2017 | 7.60x | CN¥31.53 Million | CN¥4.15 Million | CN¥31.53 Million | — |